ACRO and TransCelerate BioPharma, Inc co-developed this tool that explains control strategies, as laid out in ICH E6(R3). Control strategies can help avoid unnecessary risks, reduce the impact of risks that do occur, and increase the likelihood of detecting a risk quickly, should a risk occur during the course of a clinical trial.